Sartorius Shares Fall After Top-Line Guidance Downgrade
marketwatch.com
news
2022-10-19 08:10:00

By Maitane Sardon Shares in Sartorius AG traded lower Wednesday after the company reported results for the nine months of 2022 and adjusted its sales outlook for the current year. For the first nine months, the German pharmaceutical and laboratory equipment supplier recorded a net profit of 525.7 million euros ($518.3 million) compared with EUR307.8 million a year earlier, on sales that grew to EUR3.11 billion from EUR2.53 billion. At 0808 GMT, shares were down 12% at EUR341.20. Earnings before interest, taxes, depreciation, and amortization came in at EUR1.
